Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
5.31
-0.03 (-0.56%)
At close: May 8, 2026, 4:00 PM EDT
5.32
+0.01 (0.19%)
After-hours: May 8, 2026, 7:49 PM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $265.69 million as of May 8, 2026. Its market cap has increased by 78.90% in one year.
Market Cap
265.69M
Enterprise Value
70.56M
1-Year Change
78.90%
Ranking
Category
Stock Price
$5.31
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $265.69M, an increase of 191.66%. That is a compound annual growth rate of 21.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 265.69M | -34.91% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 277.38M |
| Compugen | 274.21M |
| Cellectis | 273.24M |
| Coherus Oncology | 269.88M |
| Artiva Biotherapeutics | 269.16M |
| Arcturus Therapeutics Holdings | 262.06M |
| Foghorn Therapeutics | 260.69M |
| Codexis | 259.06M |